Evidence map›Paper›PMID 40857279›Full record

ArticlePloS one2025

A comparative study of the changes in the quality of life among patients with homonymous hemianopia, monocular blindness, or binocular diplopia.

Ji Woong Chang

Abstract readComparative Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ji Woong ChangDepartment of Ophthalmology, Jeju National University Hospital, Jeju-si, Korea.ORCID https://orcid.org/0000-0001-6056-4201

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate changes in health-related quality of life (HRQOL), patients with homonymous hemianopia due to unilateral brain damage, monocular blindness with a best-corrected visual acuity of 20/1000 or less, or binocular diplopia for at least 6 months were enrolled. The 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) was used to evaluate the changes in HRQOL before and after the onset of the causative disease within and between the three study groups. The patients were asked to recall their state before disease onset and record it as accurately as possible for each question of the NEI VFQ-25, as well as score their current status. Among 43 included patients, 20 had homonymous hemianopia, 13 had monocular blindness, and 10 had binocular diplopia. The mean patient age was 56 years, and 12 patients were women (28%). A significant decrease in all HRQOL subscale scores was observed in the homonymous hemianopia and monocular blindness groups. In the binocular diplopia group, a lower number of subscales showed decreases in HRQOL. However, the changes in HRQOL before and after disease onset did not differ between groups. In conclusion, HRQOL change before and after homonymous hemianopia and monocular blindness did not differ. Considering the development background of the NEI VFQ-25, this questionnaire may not be sufficiently sensitive to distinguish HRQOL changes between the two disease groups. Hence, the NEI VFQ-25 might be useful for comparing HRQOL changes before and after the onset of a specific disease or before and after treatment, while not being sensitive to differentiate HRQOL differences between diseases. Thus, caution is needed when using the NEI VFQ-25 to compare HRQOL differences between disease groups.

Indexed as

BlindnessDiplopiaHemianopsiaQuality of LifeAdultAgedFemaleHumansMaleMiddle AgedSurveys and QuestionnairesVision, BinocularVisual Acuity

Identifiers

PMID40857279
PMCPMC12380287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.